Covid-19 Drug interactions
The Liverpool Drug Interactions website team developed a freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for the treatment of COVID-19 and commonly prescribed co-medications.
Find out more here.
We’ve published a video explaining the work we have done in 2020 to bring you the COVID-19 Drug Interactions website.
— COVID-19 Drug Interactions (@covidDDIs) October 12, 2020
COVID-19: Dangerous drug combinations? https://t.co/yAvptS9952 via @YouTube
Other posts
A “game-changing” antiviral pill that is part of the AGILE Coronavirus Drug Testing Initiative has been approved for use in the UK.
After a stringent review …
A new international trial to assess whether high doses of the antiparasitic drug nitazoxanide could help treat patients with COVID-19 has begun in South Africa.
Researchers …
LIVERPOOL, England, 20 April 2021 — The University of Liverpool, Liverpool School of Tropical Medicine, and the NIHR Southampton Clinical Trials Unit at the University …
People across the south are being asked to play their part in helping vital research into new COVID-19 treatments.
A ground-breaking clinical trial platform being led …
The AGILE drug testing platform has received a multi-million pound award from the UK government’s Department of Health and Social Care to fast track the …
GlaxoSmithKline and Vir Biotechnology have joined forces with researchers from the Universities of Liverpool and Southampton, who are leading an accelerated early phase trials platform …